Outlook Therapeutics, Inc.
OTLK · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$75 | -$59 | -$66 | -$53 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $5 | $6 | $8 | $5 |
| Change in WC | -$3 | $5 | -$2 | -$7 |
| Other Non-Cash | $4 | $6 | $3 | $0 |
| Operating Cash Flow | -$69 | -$43 | -$57 | -$54 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | $20 | -$2 | $6 |
| Stock Issued | $60 | $30 | $62 | $46 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$1 | -$0 | $4 |
| Financing Cash Flow | $60 | $49 | $60 | $56 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$8 | $6 | $3 | $2 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $23 | $17 | $14 | $13 |
| End Cash | $15 | $23 | $17 | $14 |
| Free Cash Flow | -$69 | -$43 | -$57 | -$54 |